Pharmacodynamics of sulfalene
T. S. Kupriyanova
Abstract
T. S. Kupriyanova
Abstract
The pharmacodynamics of sulfalene was studied. When administered to patients with chronic nonspecific lung diseases, 1 g on the first day and 0.2 g in the next 6 days, the drug circulates in the blood and is excreted in the urine throughout the entire course of treatment, after it continues to circulate in the blood for 6-9 days and is released with urine for 9-11 days. After a single dose of 2 g, it circulates in the blood for 6-7 days and is excreted in the urine for 6-9 days.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The pharmacodynamics of sulfalene was studied. When administered to patients with chronic nonspecific lung diseases, 1 g on the first day and 0.2 g in the next 6 days, the drug circulates in the blood and is excreted in the urine throughout the entire course of treatment, after it continues to circulate in the blood for 6-9 days and is released with urine for 9-11 days. After a single dose of 2 g, it circulates in the blood for 6-7 days and is excreted in the urine for 6-9 days.
Key concepts: Urine, Pharmacodynamics, Medicine, Pharmacokinetics, Pharmacology, Lung, Drug, Physiology